Skip to content
Broadstreet HEOR
  • What We Do
  • Our Work
  • Who We Are
  • Latest News & Insights
  • Let’s Talk
  • What We Do
  • Our Work
  • Who We Are
  • Latest News & Insights
  • Let’s Talk

From Discovery to Therapy: A Century of Phenylketonuria Research

  • Post published:5 March 2026

Phenylketonuria (PKU) is a rare genetic disorder that causes harmful levels of the dietary protein phenylalanine (Phe), an essential amino acid and a fundamental building block of protein, to build…

Continue ReadingFrom Discovery to Therapy: A Century of Phenylketonuria Research

Patient voices in rare disease health technology assessments (HTA) in Canada

  • Post published:4 December 2025

Qualitative research can is valuable for its potential to provide in depth insights into complex issues and is particularly valuable for capturing patient perspectives. It can be used to inform…

Continue ReadingPatient voices in rare disease health technology assessments (HTA) in Canada

Broadstreet at ISPOR Europe 2025

  • Post published:13 November 2025

Broadstreet will be featuring seven of our research projects at ISPOR Europe 2025. Subjects range from health-related quality-of-life in hypophosphatasia to physician perspectives on unmet need and treatment options in…

Continue ReadingBroadstreet at ISPOR Europe 2025

Happy 10th Birthday Broadstreet

  • Post published:18 September 2025

Continue ReadingHappy 10th Birthday Broadstreet

What we’ve been up to at Broadstreet

  • Post published:18 September 2025

Broadstreet takes of a broad variety of work in the health economics and outcomes space. We thought we would share a few of our recent publications which reflect that diversity.…

Continue ReadingWhat we’ve been up to at Broadstreet

ISPOR is coming to Canada this year and Broadstreet will be there

  • Post published:8 May 2025

ISPOR is coming to Canada this year, taking place in Montreal, May 5th to 8th. Broadstreet is pleased to be involved in six studies being presented on subjects ranging from…

Continue ReadingISPOR is coming to Canada this year and Broadstreet will be there

An old friend joins the Broadstreet team

  • Post published:3 April 2025

Broadstreet is very pleased to be welcoming an old friend and new vice president to the team, Suzanne McMullen. She has known Shelagh and Karissa since the early days of…

Continue ReadingAn old friend joins the Broadstreet team

Broadstreet at ISPOR Europe 2024

  • Post published:14 November 2024

ISPOR Europe is returning to Barcelona this year and Broadstreet is pleased to be there with six studies to present on subjects ranging from patient preferences for early oncology trial…

Continue ReadingBroadstreet at ISPOR Europe 2024

The Importance of a Human in the Loop: A Thoughtful Approach to the Use of AI

  • Post published:26 September 2024

A few weeks ago, the National Institute for Health and Care Excellence (NICE) released a position statement on the use of Artificial Intelligence (AI) in evidence generation. Their announcement came…

Continue ReadingThe Importance of a Human in the Loop: A Thoughtful Approach to the Use of AI

Our Position on the use of Artificial Intelligence (AI)

  • Post published:25 September 2024

Complex data and scientific evidence are the currency of health economics and outcomes research (HEOR), and technical tools have always played a role in how we investigate value and access…

Continue ReadingOur Position on the use of Artificial Intelligence (AI)
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Go to the next page
  • What We Do
  • Our Work
  • Who We Are
  • Latest News & Insights
  • Let’s Talk
  • The Broad Street Pump
  • Privacy Policy

info@broadstreetheor.com
300 – 177 West 7th Ave,
Vancouver, BC
Canada, V5Y 1L8
+1 604 800 0648

Follow Us

  • LinkedIn
© 2026 Broadstreet HEOR